SE0100567D0
(sv)
*
|
2001-02-20 |
2001-02-20 |
Astrazeneca Ab |
Compounds
|
WO2003027320A2
(en)
*
|
2001-09-24 |
2003-04-03 |
University Of Aarhus |
Methods for diagnosis and treatment of diseases associated with altered expression of pik3r1
|
DE60215864T2
(de)
*
|
2001-11-30 |
2007-05-31 |
Qlt Inc., Vancouver |
Behandlung von okularen neovaskularen erkrankungen
|
AU2003211424A1
(en)
*
|
2002-03-01 |
2003-09-16 |
Yamanouchi Pharmaceutical Co., Ltd. |
Nitrogen-containing heterocyclic compound
|
WO2004017950A2
(en)
*
|
2002-08-22 |
2004-03-04 |
Piramed Limited |
Phosphadidylinositol 3,5-biphosphate inhibitors as anti-viral agents
|
BRPI0414171A
(pt)
*
|
2003-09-04 |
2006-10-31 |
Warner Lambert Co |
benzo[b]tiofenos halossubstituìdos com atividade inibidora de pi3k como agentes terapêuticos
|
BRPI0506749A
(pt)
*
|
2004-01-12 |
2007-05-22 |
Applied Research Systems |
derivados de tiazol e uso dos mesmos
|
EP1786811A2
(de)
*
|
2004-08-18 |
2007-05-23 |
Pharmacia & Upjohn Company LLC |
Triazolopyridinverbindungen
|
GB0420722D0
(en)
|
2004-09-17 |
2004-10-20 |
Addex Pharmaceuticals Sa |
Novel allosteric modulators
|
KR20070083836A
(ko)
*
|
2004-10-28 |
2007-08-24 |
아이알엠 엘엘씨 |
헷지혹 경로 조절제로서의 화합물 및 조성물
|
US8030327B2
(en)
|
2004-11-08 |
2011-10-04 |
Mds K.K. |
Fused imidazole derivative
|
US7723336B2
(en)
|
2005-09-22 |
2010-05-25 |
Bristol-Myers Squibb Company |
Fused heterocyclic compounds useful as kinase modulators
|
AR059898A1
(es)
|
2006-03-15 |
2008-05-07 |
Janssen Pharmaceutica Nv |
Derivados de 3-ciano-piridona 1,4-disustituida y su uso como moduladores alostericos de los receptores mglur2
|
WO2008036272A1
(en)
*
|
2006-09-18 |
2008-03-27 |
Vertex Pharmaceuticals Incorporated |
HETEROCYCLIC INHIBITORS OF c-MET AND USES THEREOF
|
RU2009120388A
(ru)
*
|
2006-10-30 |
2010-12-10 |
Новартис АГ (CH) |
Имидазопиридазины в качестве ингибиторов липидкиназы
|
EP1972631A1
(de)
*
|
2007-03-23 |
2008-09-24 |
Novartis AG |
Imidazopyridazine als PI3K-Lipidkinaseinhibitoren
|
EA018036B1
(ru)
|
2006-11-27 |
2013-05-30 |
Х. Лундбекк А/С |
Гетероариламидные производные
|
AR064106A1
(es)
*
|
2006-12-05 |
2009-03-11 |
Bayer Schering Pharma Ag |
Derivados de 2,3-dihidroimidazo [1,2-c] quinazolina sustituida utiles para el tratamiento de enfermedades y trastornos hiper-proliferativos asociados con la angiogenesis
|
CN101502484B
(zh)
*
|
2006-12-26 |
2011-04-20 |
济南康泉医药科技有限公司 |
同载糖皮质激素和化疗药物的抗癌缓释剂
|
TW200845978A
(en)
|
2007-03-07 |
2008-12-01 |
Janssen Pharmaceutica Nv |
3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
|
TW200900065A
(en)
|
2007-03-07 |
2009-01-01 |
Janssen Pharmaceutica Nv |
3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
|
PE20090188A1
(es)
|
2007-03-15 |
2009-03-20 |
Novartis Ag |
Compuestos heterociclicos como moduladores de la senda de hedgehog
|
RU2467008C2
(ru)
|
2007-04-03 |
2012-11-20 |
Эррэй Биофарма Инк. |
СОЕДИНЕНИЯ ИМИДАЗО[1,2-a]ПИРИДИНА В КАЧЕСТВЕ ИНГИБИТОРОВ РЕЦЕПТОРНЫХ ТИРОЗИНКИНАЗ
|
NZ580394A
(en)
|
2007-04-10 |
2011-10-28 |
Lundbeck & Co As H |
Heteroaryl amide analogues as p2x7 antagonists
|
US8546394B2
(en)
|
2007-04-17 |
2013-10-01 |
Bristol-Myers Squibb Company |
Substituted [1,2,4]triazolo[4,3-A]pyrazine 11-beta-hydroxysteroid dehydrogenase inhibitors
|
MX2009012066A
(es)
*
|
2007-05-09 |
2009-11-19 |
Novartis Ag |
Imidazopirinas sustituidas como inhibidoras de cinasa de lipido p13k.
|
RU2009146851A
(ru)
*
|
2007-05-18 |
2011-06-27 |
Байер Шеринг Фарма Акциенгезельшафт (DE) |
Гетероарил-замещенные пиразольные производные, которые могут использоваться для лечения гиперпролиферативных нарушений и заболеваний, связанных с ангиогенезом
|
EP2062893A1
(de)
*
|
2007-10-18 |
2009-05-27 |
Bayer Schering Pharma AG |
Fusionierte Imidazole zur Behandlung von Krebs
|
PE20090596A1
(es)
*
|
2007-08-14 |
2009-06-07 |
Bayer Schering Pharma Ag |
Imidazoles biciclicos fusionados
|
MY152078A
(en)
|
2007-09-14 |
2014-08-15 |
Ortho Mcneil Janssen Pharm |
1',3'-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2h,1'h-[1,4']bipyridinyl-2'-ones
|
TW200922566A
(en)
|
2007-09-14 |
2009-06-01 |
Ortho Mcneil Janssen Pharm |
1,3 disubstituted 4-(aryl-X-phenyl)-1H-pyridin-2-ones
|
EP2060565A1
(de)
|
2007-11-16 |
2009-05-20 |
4Sc Ag |
Neue bifunktionelle Verbindungen die Proteinkinasen und Histonedeacetylasen hemmen
|
WO2009068482A1
(en)
*
|
2007-11-27 |
2009-06-04 |
Cellzome Limited |
Amino triazoles as pi3k inhibitors
|
JP5394404B2
(ja)
|
2008-02-06 |
2014-01-22 |
ブリストル−マイヤーズ スクイブ カンパニー |
キナーゼ阻害剤として有用な置換イミダゾピリダジン類
|
KR20100128305A
(ko)
|
2008-02-28 |
2010-12-07 |
노파르티스 아게 |
C-met 티로신 키나제 매개 질환의 치료를 위한 이미다조[1,2-b]피리다진 유도체
|
WO2009126624A1
(en)
|
2008-04-11 |
2009-10-15 |
Bristol-Myers Squibb Company |
Triazolo compounds useful as dgat1 inhibitors
|
WO2009126861A2
(en)
|
2008-04-11 |
2009-10-15 |
Bristol-Myers Squibb Company |
Triazolopyridine compounds useful as dgat1 inhibitors
|
NZ590283A
(en)
|
2008-07-14 |
2012-11-30 |
Gilead Sciences Inc |
Imidazolylpyrimidine compounds as hdac and / or cdk inhibitors
|
WO2010009155A2
(en)
|
2008-07-14 |
2010-01-21 |
Gilead Colorado, Inc. |
Fused heterocyclyc inhibitor compounds
|
EP2303841A1
(de)
|
2008-07-14 |
2011-04-06 |
Gilead Sciences, Inc. |
Oxindolylhemmerverbindungen
|
WO2010007099A1
(en)
*
|
2008-07-15 |
2010-01-21 |
Cellzome Limited |
2-aminoimidazo[1,2-b]pyridazine derivatives as pi3k inhibitors
|
US20100041663A1
(en)
|
2008-07-18 |
2010-02-18 |
Novartis Ag |
Organic Compounds as Smo Inhibitors
|
EP2326622A1
(de)
|
2008-07-28 |
2011-06-01 |
Gilead Sciences, Inc. |
Cycloalkyliden- und heterocycloalkyliden-histondeacetylasehemmerverbindungen
|
WO2010022081A1
(en)
*
|
2008-08-19 |
2010-02-25 |
Array Biopharma Inc. |
Triazolopyridine compounds as pim kinase inhibitors
|
TWI496779B
(zh)
|
2008-08-19 |
2015-08-21 |
Array Biopharma Inc |
作為pim激酶抑制劑之三唑吡啶化合物
|
US8987251B2
(en)
|
2008-08-19 |
2015-03-24 |
Array Biopharma Inc. |
Triazolopyridine compounds as PIM kinase inhibitors
|
US8895550B2
(en)
|
2008-08-19 |
2014-11-25 |
Array Biopharma Inc. |
Triazolopyridine compounds as PIM kinase inhibitors
|
US8691849B2
(en)
|
2008-09-02 |
2014-04-08 |
Janssen Pharmaceuticals, Inc. |
3-azabicyclo[3.1.0]hexyl derivatives as modulators of metabotropic glutamate receptors
|
TWI491610B
(zh)
|
2008-10-09 |
2015-07-11 |
必治妥美雅史谷比公司 |
作為激酶抑制劑之咪唑并嗒腈
|
RU2512283C2
(ru)
|
2008-11-28 |
2014-04-10 |
Янссен Фармасьютикалз, Инк. |
Производные индола и бензоксазина в качестве модуляторов метаботропных глутаматных рецепторов
|
WO2010074586A1
(en)
*
|
2008-12-23 |
2010-07-01 |
Pathway Therapeutics Limited |
Pyrazolo[1,5-a]pyridine and imidazo[1,2-a]pyridine derivatives and their use in cancer therapy
|
WO2010117926A1
(en)
|
2009-04-07 |
2010-10-14 |
Schering Corporation |
Substituted triazolopyridines and analogs thereof
|
EA020671B1
(ru)
|
2009-05-12 |
2014-12-30 |
Янссен Фармасьютикалз, Инк. |
ПРОИЗВОДНЫЕ 1,2,4-ТРИАЗОЛО[4,3-a]ПИРИДИНА И ИХ ПРИМЕНЕНИЕ В КАЧЕСТВЕ ПОЛОЖИТЕЛЬНЫХ АЛЛОСТЕРИЧЕСКИХ МОДУЛЯТОРОВ РЕЦЕПТОРОВ mGluR2
|
PT2430022E
(pt)
|
2009-05-12 |
2013-12-26 |
Janssen Pharmaceuticals Inc |
Derivados de 1,2,3-triazolo[4,3-a]piridina e a sua utilização para o tratamento ou prevenção de doenças neurológicas e psiquiátricas
|
MY153913A
(en)
|
2009-05-12 |
2015-04-15 |
Janssen Pharmaceuticals Inc |
7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
|
US8258316B2
(en)
|
2009-06-08 |
2012-09-04 |
Gilead Sciences, Inc. |
Alkanoylamino benzamide aniline HDAC inhibitor compounds
|
AU2010259042A1
(en)
|
2009-06-08 |
2011-12-15 |
Gilead Sciences, Inc. |
Cycloalkylcarbamate benzamide aniline HDAC inhibitor compounds
|
US8389526B2
(en)
|
2009-08-07 |
2013-03-05 |
Novartis Ag |
3-heteroarylmethyl-imidazo[1,2-b]pyridazin-6-yl derivatives
|
BR112012003262A8
(pt)
|
2009-08-12 |
2016-05-17 |
Novartis Ag |
compostos de hidrazona heterocíclica e seus usos para tratar câncer e inflamação
|
WO2011020861A1
(en)
|
2009-08-20 |
2011-02-24 |
Novartis Ag |
Heterocyclic oxime compounds
|
EP2496578A4
(de)
|
2009-11-05 |
2013-08-21 |
Univ Notre Dame Du Lac |
Imidazo[1,2-a]pyridin-verbindungen, ihre synthese und verfahren zu ihrer verwendung
|
CA2779951A1
(en)
*
|
2009-11-06 |
2011-05-12 |
Piramal Life Sciences Limited |
Imidazopyridine derivatives
|
DK2519522T3
(en)
*
|
2009-12-30 |
2014-12-08 |
Arqule Inc |
SUBSTITUTED IDAZOPYRIDINYL AMINOPYRIDINE COMPOUNDS
|
WO2011137155A1
(en)
|
2010-04-28 |
2011-11-03 |
Bristol-Myers Squibb Company |
Imidazopyridazinyl compounds and their uses for cancer
|
TWI541243B
(zh)
|
2010-09-10 |
2016-07-11 |
拜耳知識產權公司 |
經取代咪唑并嗒
|
US8993591B2
(en)
|
2010-11-08 |
2015-03-31 |
Janssen Pharmaceuticals, Inc. |
1,2,4-triazolo[4,3-a] pyridine derivatives and their use as positive allosteric modulators of MGLUR2 receptors
|
US9012448B2
(en)
|
2010-11-08 |
2015-04-21 |
Janssen Pharmaceuticals, Inc. |
1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of MGLUR2 receptors
|
ES2552455T3
(es)
|
2010-11-08 |
2015-11-30 |
Janssen Pharmaceuticals, Inc. |
Derivados de 1,2,4-triazolo[4,3-a]piridina y su uso como moduladores alostéricos positivos de receptores mGluR2
|
US20120129872A1
(en)
*
|
2010-11-18 |
2012-05-24 |
Kristi Anne Leonard |
Fused heteroaryl inhibitors of pro-matrix metalloproteinase activation
|
CA2822357A1
(en)
|
2010-12-22 |
2012-06-28 |
Abbvie Inc. |
Hepatitis c inhibitors and uses thereof
|
CN102030752A
(zh)
*
|
2011-01-06 |
2011-04-27 |
贵阳中医学院 |
一种制备化合物2-(咪唑并[1,2-a]吡啶-3-基)乙腈的方法
|
CN103298468A
(zh)
|
2011-02-01 |
2013-09-11 |
协和发酵麒麟株式会社 |
稠环杂环衍生物
|
PL2678329T3
(pl)
|
2011-02-25 |
2016-06-30 |
Array Biopharma Inc |
Związki triazolopirydyny jako inhibitory kinaz pim
|
JO3068B1
(ar)
|
2011-04-07 |
2017-03-15 |
Bayer Ip Gmbh |
إيميدازوبيريميدينات كمثبطات كيناز akt
|
WO2012156379A1
(en)
*
|
2011-05-13 |
2012-11-22 |
Universität Zürich |
PIK3/P110α INHIBITORS FOR PREVENTION OF RESTENOSIS BY APPLICATION AS AN IMPLANT COATING
|
KR101274986B1
(ko)
*
|
2011-07-27 |
2013-06-17 |
한국과학기술원 |
이미다조피리딘 유도체, 이를 포함하는 PI3K 및/또는 mTOR 저해제용 약학 조성물 및 PI3K 및/또는 mTOR과 연관된 질환 치료용 약학 조성물
|
US9540366B2
(en)
|
2012-07-31 |
2017-01-10 |
Kyowa Hakko Kirin Co., Ltd. |
Ring-fused heterocyclic compound
|
US8796305B2
(en)
|
2012-11-05 |
2014-08-05 |
Bayer Pharma Aktiengesellschaft |
Carboxy-substituted imidazo[1,2-a]pyridinecarboxamides and their use
|
US9624214B2
(en)
|
2012-11-05 |
2017-04-18 |
Bayer Pharma Aktiengesellschaft |
Amino-substituted imidazo[1,2-a]pyridinecarboxamides and their use
|
US9126998B2
(en)
|
2012-11-05 |
2015-09-08 |
Bayer Pharma AG |
Amino-substituted imidazo[1,2-a]pyridinecarboxamides and their use
|
US8778964B2
(en)
|
2012-11-05 |
2014-07-15 |
Bayer Pharma Aktiengesellschaft |
Hydroxy-substituted imidazo[1,2-a]-pyridinecarboxamides and their use
|
TW201439090A
(zh)
*
|
2012-11-30 |
2014-10-16 |
Astellas Pharma Inc |
咪唑並吡啶化合物
|
CN105121439A
(zh)
|
2013-02-19 |
2015-12-02 |
辉瑞公司 |
作为pde4亚型抑制剂用于治疗cns和其他病症的氮杂苯并咪唑化合物
|
WO2014195333A1
(de)
*
|
2013-06-04 |
2014-12-11 |
Bayer Pharma Aktiengesellschaft |
3-aryl-substituierte imidazo[1,2-a]pyridine und ihre verwendung
|
JO3368B1
(ar)
|
2013-06-04 |
2019-03-13 |
Janssen Pharmaceutica Nv |
مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2
|
JO3367B1
(ar)
|
2013-09-06 |
2019-03-13 |
Janssen Pharmaceutica Nv |
مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2
|
ME03518B
(de)
|
2014-01-21 |
2020-04-20 |
Janssen Pharmaceutica Nv |
Kombinationen mit positiven allosterischen modulatoren von metabotropem glutamatergen rezeptor vom subtyp 2 und deren verwendung
|
WO2015110435A1
(en)
|
2014-01-21 |
2015-07-30 |
Janssen Pharmaceutica Nv |
Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use
|
ES2672797T3
(es)
|
2014-02-13 |
2018-06-18 |
Incyte Corporation |
Ciclopropilaminas como inhibidores de LSD1
|
HUE045725T2
(hu)
|
2014-02-13 |
2020-01-28 |
Incyte Corp |
Ciklopropilaminok mint LSD1 inhibitorok
|
ES2760261T3
(es)
|
2014-02-13 |
2020-05-13 |
Incyte Corp |
Ciclopropilaminas como inhibidores de LSD1
|
US9527835B2
(en)
|
2014-02-13 |
2016-12-27 |
Incyte Corporation |
Cyclopropylamines as LSD1 inhibitors
|
CA2939793A1
(en)
|
2014-02-19 |
2015-08-27 |
Bayer Pharma Aktiengesellschaft |
3-(pyrimidine-2-yl)imidazo[1,2-a]pyridines
|
CN106715426A
(zh)
|
2014-03-21 |
2017-05-24 |
拜耳医药股份有限公司 |
氰基取代的咪唑并[1,2‑a]吡啶甲酰胺及其用途
|
ES2692243T3
(es)
*
|
2014-03-24 |
2018-11-30 |
Arqule, Inc. |
Proceso para preparar 3-(3-(4-(1-aminociclobutil)fenil)-5-fenil-3H-imidazo[4,5-b]piridin-2-il)piridin-2-amina
|
AU2015249809B2
(en)
*
|
2014-04-22 |
2019-05-02 |
Arqule, Inc. |
Salts and polymorphs of a substituted imidazopyridinyl-aminopyridine compound
|
CA2947374A1
(en)
|
2014-05-02 |
2015-11-05 |
Bayer Pharma Aktiengesellschaft |
Enantiomers of the n-(2-amino-5-fluoro-2-methylpentyl)-8-[(2,6-difluorobenzyl)oxy]-2-methylimidazo[1,2-a]pyridine-3-carboxamide, as well as of the di- and trifluoro derivatives for the treatment of cardiovascular diseases
|
US9758523B2
(en)
|
2014-07-10 |
2017-09-12 |
Incyte Corporation |
Triazolopyridines and triazolopyrazines as LSD1 inhibitors
|
US9695168B2
(en)
|
2014-07-10 |
2017-07-04 |
Incyte Corporation |
Substituted imidazo[1,5-α]pyridines and imidazo[1,5-α]pyrazines as LSD1 inhibitors
|
WO2016007722A1
(en)
|
2014-07-10 |
2016-01-14 |
Incyte Corporation |
Triazolopyridines and triazolopyrazines as lsd1 inhibitors
|
WO2016007736A1
(en)
|
2014-07-10 |
2016-01-14 |
Incyte Corporation |
Imidazopyrazines as lsd1 inhibitors
|
EP3172210B1
(de)
|
2014-07-24 |
2020-01-15 |
Pfizer Inc |
Pyrazolopyrimidin verbindungen
|
KR102061952B1
(ko)
|
2014-08-06 |
2020-01-02 |
화이자 인코포레이티드 |
이미다조피리다진 화합물
|
CN107001361A
(zh)
|
2014-12-02 |
2017-08-01 |
拜耳医药股份有限公司 |
杂芳基取代的咪唑并[1,2‑a]吡啶及其用途
|
MX2017012699A
(es)
|
2015-04-03 |
2018-02-09 |
Incyte Corp |
Compuestos heterociclicos como inhibidores de demetilasa 1 especifica de lisina (lsd1).
|
KR20180051523A
(ko)
|
2015-08-12 |
2018-05-16 |
인사이트 코포레이션 |
Lsd1 저해제의 염
|
CA2998375A1
(en)
|
2015-09-17 |
2017-03-23 |
Marvin J. Miller |
Benzyl amine-containing heterocyclic compounds and compositions useful against mycobacterial infection
|
GB201602527D0
(en)
*
|
2016-02-12 |
2016-03-30 |
Glaxosmithkline Ip Dev Ltd |
Chemical compounds
|
CN107304202A
(zh)
*
|
2016-04-20 |
2017-10-31 |
苏州苏领生物医药有限公司 |
五元杂环类化合物及其制备方法、药物组合物和用途
|
WO2017181973A1
(zh)
*
|
2016-04-20 |
2017-10-26 |
苏州苏领生物医药有限公司 |
五元杂环类化合物及其制备方法、药物组合物和用途
|
SG11201809299QA
(en)
|
2016-04-22 |
2018-11-29 |
Incyte Corp |
Formulations of an lsd1 inhibitor
|
WO2017197151A1
(en)
|
2016-05-11 |
2017-11-16 |
Emory University |
Phosphotidylinositol 3-kinase inhibitors
|
WO2018013430A2
(en)
|
2016-07-12 |
2018-01-18 |
Arisan Therapeutics Inc. |
Heterocyclic compounds for the treatment of arenavirus infection
|
WO2018184976A1
(de)
|
2017-04-05 |
2018-10-11 |
Bayer Pharma Aktiengesellschaft |
Substituierte imidazo[1,2-a]pyridincarboxamide und ihre verwendung
|
CN111225917A
(zh)
|
2017-10-24 |
2020-06-02 |
拜耳股份公司 |
取代咪唑并吡啶酰胺及其用途
|
WO2020047198A1
(en)
|
2018-08-31 |
2020-03-05 |
Incyte Corporation |
Salts of an lsd1 inhibitor and processes for preparing the same
|
KR20220002890A
(ko)
|
2019-03-19 |
2022-01-07 |
뵈링거 잉겔하임 애니멀 헬스 유에스에이 인코포레이티드 |
구충성 아자-벤조티오펜 및 아자-벤조푸란 화합물
|
WO2020216669A1
(de)
|
2019-04-23 |
2020-10-29 |
Bayer Aktiengesellschaft |
Phenylsubstituierte imidazopyridinamide und ihre verwendung
|
WO2021221445A1
(ko)
*
|
2020-04-27 |
2021-11-04 |
주식회사 오토텍바이오 |
Ubr 박스 도메인 리간드로의 화합물
|
KR20230028268A
(ko)
|
2020-05-29 |
2023-02-28 |
뵈링거 잉겔하임 애니멀 헬스 유에스에이 인코포레이티드 |
구충성 헤테로시클릭 화합물
|
CN113135913B
(zh)
*
|
2021-04-28 |
2022-05-24 |
沈阳药科大学 |
3-取代基-6-吡啶类取代基-六元并五元杂环类衍生物及其制法与用途
|